Start-up EBViously (IMAGE)

German Center for Infection Research

Start-up EBViously

Caption

The start-up EBViously is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV).

Credit

CDC/Dr. Paul M Feorino/EBViously/DZIF

Usage Restrictions

Use only in connection with news article

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.